no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A clinical, epidemiological and laboratory study on avoiding the risk of transmitting viral hepatitis during vaccinations with the Dermojet protected by an anticontaminant disposable device
|
Dimache, G. |
|
1997 |
15 |
9 |
p. 1010-1013 4 p. |
article |
2 |
Antibody efficacy as a keen index to evaluate influenza vaccine effectiveness
|
Hirota, Yoshio |
|
1997 |
15 |
9 |
p. 962-967 6 p. |
article |
3 |
Antibody response to Actinobacillus pleuropneumoniae antigens after vaccination of pigs bred for high and low immune response
|
Magnusson, U. |
|
1997 |
15 |
9 |
p. 997-1000 4 p. |
article |
4 |
Antigen presenting vesicle obtainable from antigen presenting cells; B-lymphocyte, macrophage, dendrite antigen-presenting cell-derived exosome for use as vaccine for immune disease, infection, AIDS and cancer therapy and prevention
|
|
|
1997 |
15 |
9 |
p. 1045- 1 p. |
article |
5 |
Characterization of Schistosoma mansoni 44.7 56.8 kDa egg antigens recognized by human monoclonal antibodies which induce protection against experimental infection and proliferation of peripheral blood mononuclear cells from schistosomiasis patients
|
Hirsch, Cristine |
|
1997 |
15 |
9 |
p. 948-954 7 p. |
article |
6 |
DNA encoding mammalian IA-2-beta protein; recombinant insulinoma-associated antigen-2-beta production using a baculo virus vector, for use as a recombinant vaccine, antidiabetic or diagnostic agent
|
|
|
1997 |
15 |
9 |
p. 1045- 1 p. |
article |
7 |
Effect of lipid modification on the physicochemical, structural, antigenic and immunoprotective properties of Haemophilus influenzae outer membrane protein P6
|
Yang, Yan-Ping |
|
1997 |
15 |
9 |
p. 976-987 12 p. |
article |
8 |
Expression of a synthetic pertussis toxin operon in Escherichia coli
|
Pozza, Tania Dalla |
|
1997 |
15 |
9 |
p. 968-975 8 p. |
article |
9 |
Further evaluation of the safety and protective efficacy of live attenuated hepatitis A vaccine (H2-strain) in humans
|
Mao, J.S. |
|
1997 |
15 |
9 |
p. 944-947 4 p. |
article |
10 |
Generating an immune response to prostate-specific antigen; by introducing pox virus vector containing antigen encoding DNA
|
|
|
1997 |
15 |
9 |
p. 1045- 1 p. |
article |
11 |
Haemolytic activities of plant saponins and adjuvants. Effect of Periandra mediterranea saponin on the humoral response to the FML antigen of Leishmania donovani
|
Santos, Wania Renata |
|
1997 |
15 |
9 |
p. 1024-1029 6 p. |
article |
12 |
Immunoresponse to hepatitis B vaccination and adherence campaign among injecting drug users
|
Lugoboni, Fabio |
|
1997 |
15 |
9 |
p. 1014-1016 3 p. |
article |
13 |
Induction of cross-reactive cytotoxic T-lymphocyte responses specific for HIV-1 gp120 using saponin adjuvant (QS-21) supplemented subunit vaccine formulations
|
Newman, M.J. |
|
1997 |
15 |
9 |
p. 1001-1007 7 p. |
article |
14 |
Infectious Japanese-encephalitis virus cDNA clone producing a highly attenuated recombinant Japanese-encephalitis virus and its vaccine; mutant virus IC47 production by point mutation for use as a recombinant vaccine
|
|
|
1997 |
15 |
9 |
p. 1045- 1 p. |
article |
15 |
Influenza vaccination in patients with asthma: effect on peak expiratory flow, asthma symptoms and use of medication
|
Ahmed, Ala'Eldin H. |
|
1997 |
15 |
9 |
p. 1008-1009 2 p. |
article |
16 |
Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants
|
Benne, C.A. |
|
1997 |
15 |
9 |
p. 1039-1044 6 p. |
article |
17 |
Innocuity studies of SAG-2 oral rabies vaccine in various Zimbabwean wild non-target species
|
Bingham, J. |
|
1997 |
15 |
9 |
p. 937-943 7 p. |
article |
18 |
Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins
|
Sjölander, Anders |
|
1997 |
15 |
9 |
p. 1030-1038 9 p. |
article |
19 |
New isolated prostate cancer associated polypeptides; prostate-specific antigen gene cloning and expression in Escherichia coli, yeast or mammal cell culture, for use as an antitumor agent; monoclonal antibody for cancer diagnosis
|
|
|
1997 |
15 |
9 |
p. 1045- 1 p. |
article |
20 |
OspA lipoprotein of Borrelia burgdorferi is a mucosal immunogen and adjuvant
|
Erdile, Lorne F. |
|
1997 |
15 |
9 |
p. 988-995 8 p. |
article |
21 |
Relative immunogenicity and efficacy of two synthetic chimeric peptides of fimbrin as vaccinogens against nasopharyngeal colonization by nontypeable Haemophilus influenzae in the chinchilla
|
Bakaletz, Lauren O. |
|
1997 |
15 |
9 |
p. 955-961 7 p. |
article |
22 |
Selection of an adjuvant for vaccination with the malaria antigen, MSA-2
|
Pye, David |
|
1997 |
15 |
9 |
p. 1017-1023 7 p. |
article |